
PCOS care platforms are shifting the conversation from fertility to lifelong metabolic health
Dr. Dereck Mush, MD, MBADayTwo uses gut microbiome profiling and predictive algorithms to deliver highly personalized nutritional recommendations. Designed to control blood sugar spikes and improve metabolic clinical outcomes, the platform is purchased primarily by employers and health plans.
Notable investors: Cathay Innovation, aMoon Venture Partners, Marius Nacht.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA